First up, Mark Zuckerberg and Priscilla Chan are shifting their philanthropic focus to biology and AI, aiming to accelerate disease cures. They've long supported education and housing, but now they're betting on AI to speed up scientific breakthroughs.

Next, the Chan Zuckerberg Initiative is bringing all its scientific efforts under the new name Biohub. They're also integrating EvolutionaryScale, an AI research lab, into their operations. Alex Rives, co-founder of EvolutionaryScale, will lead the science efforts, and the lab's team will join Biohub.

Meanwhile, Chan and Zuckerberg recently hosted a gathering of about 50 AI researchers and tech leaders to discuss this new direction. Notable attendees included former Meta executives and other prominent figures in tech and science.

What they're saying is that the Biohub model has been their most impactful project, and they want to expand it. Chan emphasized their goal to empower scientists to take risks and explore bold questions in biology without focusing on a specific disease.

Finally, this shift hasn't been without controversy. Some communities have benefited from their earlier projects, like a school in East Palo Alto offering free tuition and health care, which is set to close in 2026. Despite this, Zuckerberg and Chan remain committed to their ambitious goal of curing all diseases, believing it's worth pursuing.

First up, Mark Zuckerberg shared an intriguing perspective on AI and disease prevention. He mentioned that while biologists find the goal of curing all diseases ambitious, AI experts think itâ€™s not ambitious enough. Zuckerberg believes that the AI perspective is gradually gaining ground.

Next, Microsoft is stepping into the AI arena with a focus on "Humanist Superintelligence." AI chief Mustafa Suleyman explained that Microsoft aims to create AI that serves humanity, rather than just maximizing performance. This effort is part of Microsoft's strategy to catch up in the competitive race toward artificial general intelligence, amidst similar pursuits by companies like OpenAI and Google.

Meanwhile, OpenAI CEO Sam Altman discussed the dual nature of AI's future. He described AI as both a powerful tool for progress and a potential source of new threats. Altman emphasized the messy evolution of AI and its significant impact on global ethics and economies, though he stopped short of advocating for stronger regulation.

In other news, Palantir's CEO Alex Karp criticized Wall Street analysts for not understanding the success of tech companies like his. He argued that traditional thinking fails to appreciate the value of AI-driven software, which has been a boon for Palantir and its shareholders.

Finally, for the Star Trek fans out there, Lego is releasing a 3,600-piece USS Enterprise set. It goes on sale November 28th for $399.99, adding a new dimension to their collection for enthusiasts.